A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. over alleged misrepresentations about its acquisition of Fabric Genomics. The lawsuit, covering investors who purchased shares between April 16, 2025 and May 4, 2026, claims the company and certain executives made false statements about the strategic and financial benefits of the deal. GeneDx had touted Fabric as an AI-driven growth catalyst that would unlock recurring software revenue and reduce costs, but allegedly concealed significant integration problems and operational disconnects. On May 4, 2026, the company reported first-quarter results that missed revenue estimates, slashed full-year guidance to $475 million–$490 million from $540 million–$550 million, and recorded a $31.2 million impairment loss on Fabric, wiping out roughly 94% of the cash paid a year earlier. The stock plunged 49.2% the next day, from $67.93 to $34.51. Investors have until August 3, 2026 to seek lead plaintiff status.
GeneDx Holdings Corp.Securities fraud lawsuit over alleged misrepresentations about Fabric Genomics acquisition; stock plunged 49.2% after revenue miss and guidance cut.
Acquisition by GeneDx resulted in $31.2 million impairment loss, wiping out 94% of cash paid; Fabric's integration problems cited.